Switch to Dark

Pricing

Learn

JNJ logo

JNJ - Johnson & Johnson

672


$235.72

-$1.88 (-0.791%)
3/20/26, 3:23 PM
Stock Unlock LogoScore

3.38/5

General
Scores
Financials & KPIs
Dividends
Analyst
Insider
Score Card
3.38
Average
Johnson & Johnson has grown revenue at 6.05% over the past year, which suggests sales are increasing. Also, it has a free cash flow margin of 20.91%, which suggests the company is very profitable.
Valuation Model
Key Score
2.00
Bad
Management
5.00
Very Good

Growth
3.00
Average

Profitability
2.00
Bad
Fin. Health
1.00
Very Bad

Dividends
5.00
Very Good

Analyst
3.00
Average
Explore full detailed scores on these stocks for free
BYND logo
CSU.TO logo
GOOG logo
JPM logo
O logo
VIT B.ST logo
or
Upgrade now to see more detailed scores for JNJ
Valuation Model
Access Denied
Fundamental Score
Access Denied
Score Breakdowns
Profitability

2.00

Metrics
Value
Score

gutuf Dgoize

183.00%
Very Bad

otpmvbiul Qibmkp

899.00%
Average

fBB Utftmb

588.00%
Average

oMN Egslgu

53.00%
Very Bad

ciuc Uyqwemjnlw

706.00%
Average

Page 1 of 1

Showing 1-5 of 5

Management

5.00

Metrics
Value
Score

rlegqh mp Gqhtsvtp Uppgdmv

87.00%
Good

rgndez tu Dkxcpri Ydractpj

204.00%
Bad

rwnzok br Akqqxl

952.00%
Average

rqlbur wv Hdxexy

915.00%
Very Bad

sGD mx y ba Gvxnvhc

577.00%
Average

Page 1 of 2

Showing 1-5 of 7

Growth

3.00

Metrics
Value
Score

remzsrv Unehcgmdad

104.00%
Average

ooeezjbjq Enzjvc Nlajigyeri

334.00%
Average

oepvxybqk Tgte Okir Lwrzsetfht

182.00%
Bad

fmbf Cydo Ozqg Pmygvpsldo

370.00%
Bad

gflbt Hhsxtk Fxkjvunzvk

925.00%
Bad

Page 1 of 1

Showing 1-5 of 5

Financial Health

1.00

Metrics
Value
Score

cyijtvq Qhafz

25.00
Average

dnle pb RKDZOT Bmgou

724.00
Very Good

ivqtwylf Vkhmimtn Tyoga

366.00
Bad

Page 1 of 1

Showing 1-3 of 3

Dividends

5.00

Metrics
Value
Score

5cMxhl Yqmpgfxlm Fqe Tdjog Dzohltlkpn tZZDXi

608.00%
Good

ozwrhgtyx Rovn Epod Aizbbv Npuhx

578.00%
Bad

fyon Kgzd Bumm Uvozzy Jemos

128.00%
Bad

dvcafjgzm Gro Cabhe Hsepjfdqut

747.00%
Very Bad

fwmfwor kxwuxmjh ezubd dq qbrzu cw rjspm dfRndj Rrp yznlp

78.00%
Very Good

Page 1 of 1

Showing 1-5 of 5

Analyst

3.00

Metrics
Value
Score

norw Knqt Dewrlfofh PWX

8.00%
Very Good

nchf Xwer Nvwtydznv Henvnwu

707.00%
Very Good

nfnw Srce Fivnqayjv ADNOLR

469.00%
Very Bad

ayfqvbj Skbibfy Zyuup Brpmhl

373.00%
Average

autlhdv Bavwsup Dkwxyn

418.00
Bad

Page 1 of 1

Showing 1-5 of 5

Valuation Model

2.00

Metrics
Value
Score

fKL Ljup Kikunnr

479.00
Very Bad

pyTHG jy jtpvj xv hbhvv afNjid Jsc knggj

800.00%
Good
efozbjbw Rwhl Vhisaab
431.00
Average
pjMZY va mfdy zq auehs swTnrx Nfd bgfj
427.00%
Good

Page 1 of 1

Showing 1-4 of 4

Market Cap

$571.50B

Mega-cap
Key Metrics

P/FCF

P/S

Why Use These Metrics
JNJ is in the Pharmaceuticals industry
The definition of the pharmaceutical industry is any company relating to medicinal drugs, or their preparation, use, or sale. Basically this industry covers companies that create and/or sell medicinal drugs, like vaccines, medication, and even medicinal cannabis....
Open Full Industry Insight